MRK looks good here up to 88. Safest entry is waiting on a retest of the channel around 80. Looks even better if you believe the market is going to sell-off after the fed cuts rates. Everything sells off in bear markets, but healthcare is a "safety" investment that typically a lot of people will put money into when the market starts to sell-off the first time off...
Merck ended the day near the bottom of its parallel channel, right above a high-volume support node at 8.19 and a trend line that's parallel with channel bottom. After hours, the price has moved below both the support and the trend line, but in my experience, after hours moves don't necessarily mean much. The real test will be tomorrow after market open. If the...
On the daily chart of NYSE:MRK it seems that a nice breakout rally is setting up, with $84 as a good point to evaluate your position. The chart accompanying this post is merely a look at the nature of declines that a stock can suffer, to get back to the 2000 price level may take a possible 21 years, that is a long to hold and pray. It teaches us the lesson that...
With market internals showing signs of weakness and less and less mega pharma co.'s hitting new highs, FlashPoint Trading Academy has been on the hunt for a good shorting opportunity.
We've made plenty of money trading Merck to the long side and now its time to reverse our position. As you can see by the above chart pattern, MRK's price action has formed an...
three months long bias.
expecting bigger retracement to the origin of the move.
waiting for new areas of demand on the weekly to be created or long at the fresh area of demand around 60 dollar a share
Hey everyone,
Moving away from the typical crypto posts today.
We are checking out MRK.
This stock has seen some hefty losses in the past few days, pushing the RSI into a oversold area
The increasing bear volume has not been supportive, and the price is breaking past the .382 fib level.
The stock is looking to find support, but the last few days have not...
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
MRK
